Lisa Lynn Pittman

I represent companies and people across the cannabis supply chain on operational, corporate, regulatory, licensing, and litigation issues, such as partnership disputes, breach of contract, and product liability. Risk management and mitigation are the name of the game in cautiously scaling a business in an environment of the unknown involving constantly evolving laws and policies. From the inception of the Texas Compassionate Use Act of 2015, I have been advocating for patient access and representing businesses in competitive medical marijuana licensing, investment, corporate structure, contracts, compliance, marketing strategies, FDA labeling guidance, governmental and overall proactive risk prevention strategies to prevent incurring law enforcement or administrative action and lawsuits. The burgeoning hemp industry is in the crosshairs of federal DEA enforcement at .4% THC, inconsistent state positions on novel psychoactive cannabinoids such as delta 8, delta 10, HHC, and THC-O, some of which were made legal by the 2018 Farm Bill, which was intended to allow interstate commerce and state regulation of industrial hemp and non-psychoactive CBD. I spent two years in Colorado under the predecessor 2014 Farm Bill Pilot Program, and thoroughly learned the entire cannabis industry in one of the most mature state legal markets while obtaining my Colorado Bar License. There is no substitute for that in the trenches experience and those networking contacts, which I brought back to Texas to represent Texans and those wanting to invest in Texas and the surrounding Southwestern and Southeastern states. I also assist with investment and participation in international endeavors, and have a network of attorneys in numerous other jurisdictions.